Ventz Marcus, Quinkler M
Klinische Endokrinologie, Charité Campus Mitte, Charité Universitätsmedizin Berlin, Berlin.
Dtsch Med Wochenschr. 2010 Oct;135(41):2024-30. doi: 10.1055/s-0030-1267477. Epub 2010 Oct 5.
Primary hyperparathyroidism is a common endocrine disease. Since introduction of automated routine measurement of serum calcium the detection of primary hyperparathyroidism has increased significantly. The classical symptoms such as kidney stones, gastrointestinal and bone manifestation are rarely seen nowadays. For this reason, an elevated parathyroid hormone level in a patient with hypercalcemia confirms primary hyperparathyroidism in 95 % of cases. Currently 80 % of these patients are asymptomatic, and therefore criteria for diagnosis and treatment have been discussed on several consensus conferences. After biochemical confirmation has been obtained further diagnostic test aim at locating the tumor should be by ultrasound and 99m TC-sestamibi scintigraphy. The improved diagnostic work-up had led to a better surgical approach with minimally invasive and endoscopic techniques. In addition, quick intraoperative parathyroid hormone measurements confirm immediately the success of surgical treatment. Non-surgical treatment in asymptomatic and elderly patients may be justified. Bisphosphonates are the first choice for medical treatment in patients with bone manifestation and cinacalcet may be given to patients to lower calcium and parathyroid hormone levels.
原发性甲状旁腺功能亢进症是一种常见的内分泌疾病。自从采用血清钙自动常规检测以来,原发性甲状旁腺功能亢进症的检出率显著增加。如今,肾结石、胃肠道和骨骼表现等经典症状已很少见。因此,高钙血症患者甲状旁腺激素水平升高在95%的病例中可确诊为原发性甲状旁腺功能亢进症。目前,这些患者中有80%无症状,因此在多次共识会议上对诊断和治疗标准进行了讨论。在获得生化确诊后,进一步旨在定位肿瘤的诊断性检查应采用超声和99m锝-甲氧基异丁基异腈闪烁扫描。诊断方法的改进带来了更好的手术方法,采用微创和内镜技术。此外,术中快速甲状旁腺激素测量可立即确认手术治疗的成功。无症状和老年患者的非手术治疗可能是合理的。双膦酸盐是有骨骼表现患者药物治疗的首选,西那卡塞可用于降低患者的钙和甲状旁腺激素水平。